Sign in to view content

Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial

Peter A. Campochiaro, MD

Video
Published 2021

Related

BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Annual Meeting Talks
2019
Defining and Addressing Wet AMD Non-responders
Rishi P. Singh, MD
Updates from the Field
2019
Macular Edema as Presenting Feature of Peripheral Exudative Hemorrhagic Chorioretinopathy
Amol D Kulkarni, MD, FASRS
On Demand Cases, Courses, and Papers
2020

Category: Pharmacology

See more